Related Experiment Videos

Treatment of diabetic retinopathy

F L Ferris¹, M D Davis, L M Aiello

¹National Eye Institute, National Institutes of Health, Bethesda, MD, USA. rickferris@nei.nih.gov

The New England Journal of Medicine

|August 26, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.

Journal of breath research·2022

Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.

Lupus·2015

Clinical measurement of saturation discrimination.

Applied optics·2010

Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis.

Journal of clinical neuromuscular disease·2008

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.

Eye (London, England)·2008

Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2007

See all related articles